Fig. 2

Comparison of undetectable HBV DNA between initial baseline data and 6 months data of the treatment of ETV-Generic reported no significant, p = 0.05, showing the anti-viral efficacy maintained. HBV DNA, Hepatitis B deoxyribonucleic acid; ETV-Brand, entecavir-brand drugs; ETV-Generic, entecavir-generic drugs